There is evidence of a recent reduction in the number of elective operations for chronic peptic ulcer. -5 Nevertheless, peptic ulceration remains a serious problem and was responsible for nearly 14 000 deaths in England and Wales over the years 1982-4.6 Of these ulcer related deaths 7000 were associated with bleeding and 5000 with perforation and threequarters of the mortality occurred in patients over the age of 70 years.' It has recently been reported that the incidence of perforated peptic ulcer is increasing in elderly men and women in contrast with a decrease in the younger age groups.7 Non-steroidal antiinflammatory drugs (NSAID) have been associated both with the development of peptic ulceration and the life threatening complications of haemorrhage and perforation."'' As 22 for NSAID ingestion could be identified. There was no relationship between the length of time of NSAID ingestion, which ranged from one week to over three years, and the development of bleeding or perforation. Likewise there were equal numbers of bleeding and perforated peptic ulcers in patients with rheumatoid and osteoarthritis. A history of dyspepsia before the acute event was obtained in 41-8% of patients using NSAIDs compared with 75.5% of patients not taking anti-inflammatory agents (X2=25-89, p<0-0001). An acute life threatening complication was the first sign of a peptic ulcer in 58-2% of patients taking NSAIDs. In six patients taking NSAIDs a 'silent' perforation had been present for more than three days and this presentation was not seen in patients who had not used anti-inflammatory agents. The various drugs being taken on admission are listed in Table 1 and six patients were taking two different anti-inflammatory agents concurrently. Fifty nine patients taking NSAIDs had a definite history of dyspepsia and seven had been started on anti-ulcer medication for a proven peptic ulcer (cimetidine five, ranitidine two, in adequate dosage). Seventeen of 94 patients not using anti-inflammatory medication were on full Non-steroidal anti-inflammatory drugs and life threatening complications ofpeptic ulceration antiulcer medical therapy (cimetidine 13, ranitidine four, in adequate dosage). Repeat prescriptions of NSAIDs had been given to 45 patients with a definite history of dyspepsia lasting more than one month, and to 20 of these patients with dyspepsia of longer than one year duration. The incidence of NSAID use in the control group of hospital patients was 123/1246 (9-9%). The individual anti-inflammatory agents used in three age groups are shown in Table 2 . Non-steroidal antiinflammatory drug use was more commonly seen in the elderly patients. The use of other drugs of all other types was not significantly different between the control patients and the study group. Patients receiving NSAIDs who developed a life Fi*ures arc number of patients; in parentheses number of deaths.
threatening complication were on average older than those not using these drugs with median ages of 74 years and 59 years respectively (x2=22*8, p<000l).
The incidence of pre-existing medical conditions was similar in the two groups except for cardiovascular disease which was twice as common in patients using NSAIDs. There were similar numbers of gastric and duodenal ulcers, perforation and haemorrhage in these patients. Table 3 relates NSAID use to age, sex, and overall mortality. The majority of patients using NSAIDs who developed perforation or bleeding were over 60 years of age and almost all the mortality was seen in these cases. The age range in patients not using NSAIDs was more equally distributed with mortality again being closely related to age. Women were more common than men in those patients taking anti-inflammatory agents whereas the converse was true in patients not using these drugs. The overall mortality was higher in patients using
NSAIDs at 43-3% v 18-1% (X'=16-12, p<0-001).
This difference was marked in younger patients (mortality for <69 years 34-1% with NSAID use and 6-8% with no NSAID history respectively) although mortality was still increased in the elderly (mortality for >70 years 47 4% and 37 1% respectively). Sixty one of the 78 deaths (78-2%) occurred in patients using an anti-inflammatory drug. Large ulcers (>2 cm diameter) were seen in 37-6% of patients using NSAIDs in contrast with 24-5% of those not using these drugs (X'=4A43, p<0.05). Two or more ulcers were seen in seven patients taking NSAIDs and in seven patients not taking these drugs.
OPERATIONS
One hundred and eighty nine patients underwent emergency surgery. The postoperative mortality was 18-0% and varied with age, the site of ulcer and the complication. Of 81 patients operated on for bleeding 43 were over 70 years of age with an operative mortality of 34-9% and 38 were under 70 years of age with a corresponding mortality of 7-9%. Of 104 patients operated for perforation 50 were over 70 years of age with an operative mortality of 22% compared with 9-3%Yo in 54 patients under 70 years of age. There was a higher mortality associated with gastric ulcer complications than the corresponding duodenal ulcer emergencies and this was independent of age. Twenty six of the 34 postoperative deaths were considered by the pathologist to be related to medical causes, and in eight patients surgical factors appeared to be responsible for the deaths. The relationship of NSAID use to age, sex, and operative mortality is shown in Table 4 . Patients using NSAIDs who had an operation for a peptic ulcer complication were older than those not taking these drugs with median ages of 73 years v 59 years (x3=19-6, p<0-001). These patients, within the constraints of this study, also had a higher incidence of pre-existing cardiovascular disease. The operative mortality in patients taking NSAIDs was 24-3% in contrast with 10-5% in patients not using these drugs (X2=6-609 p<002) and this difference in mortality was particularly marked in patients less than 60 years of age. In both groups of patients operative deaths were closely related to age. The length of postoperative stay in survivors was similar in the two groups of patients with a mean±SD of 12-3±7-45 days and 10-9±5-59 days respectively.
Discussion
Although several epidemiological studies have reported a fall in the incidence of perforated peptic ulcer over the last decade4 '4 the Registrar General's figures6 show the total number of patients dying from bleeding or perforation to have remained constant over the last three years. It is of interest and as yet unexplained that these same sources have identified a decreased number of perforations in men in contrast with an increase in women, with the elderly being particularly affected.7 Upper gastrointestinal haemorrhage from peptic ulceration has in the same time period increased in incidence and this increase is exclusively in patients over the age of 60 years." The use of NSAIDs has been suggested as the prime reason for these epidemiological changes.'"" 12 We have specifically studied patients with serious complications of peptic ulceration who would normally require surgery for cure and this report, in contrast with other published material, has included all deaths related to peptic ulcer complications in a given area. The importance of including sudden deaths is emphasised as over half the total ulcer related mortality was accounted for by patients dying at home or in hospital before surgical intervention.
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that quoted in hospital based studies from Oxford' and Ipswich' and this may relate to our inclusion of all at home deaths. Furthermore the incidence of perforated ulcer is higher in the north-west than in the south of England.'4 The incidence of bleeding peptic ulcer has not been calculated as this study did not include the majority of patients with bleeding peptic ulcers who settled without surgery. Many of the patients in this study were elderly with women being significantly older than men. The overall mortality associated with a bleeding or perforated peptic ulcer was closely related to age as there was a three-fold greater chance of dying in patients over 70 years and deaths were rare under the age of 60 years. The mortality for gastric ulcer complications was almost twice that of duodenal ulcer emergencies confirming previous observations.' I The relationship of NSAIDs to peptic ulceration remains controversial as there is an increased incidence of peptic ulceration in rheumatoid arthritis but not in osteoarthritis. 7 Non-steroidal antiinflammatory drugs inhibit the enzyme prostaglandin cyclo-oxygenase and thereby reduce the biosynthesis of prostaglandins in the stomach. This may compromise the efficacy of the gastric mucosal barrier and lead to mucosal damage."' The use of individual anti-inflammatory agents has been related to the bleeding and perforation complications of peptic ulceration7-' and ulceration in more distant areas of the bowel has been reported with slow release preparations of NSAIDs.22 2' Recent studies, which did not include patients dying at home, have shown NSAID use in a large proportion of patients requiring emergency surgery for perforated" " and bleeding' 12 ' peptic ulcers. In our study 60% of patients with life threatening complications of peptic ulceration had a definite history of NSAID use and it is of interest that a high proportion of these patients using NSAIDs were women. Most prescriptions were for osteoarthritis, rheumatoid disease and other rheu-matic disorders although in 29 patients no reason for NSAID use could be found despite a close scrutiny of their records. It is worrying that prescriptions for NSAIDs were repeatedly given to a large number of patients with a clear history of dyspepsia. We have listed the individual anti-inflammatory agents with piroxicam, indomethacin, ibuprofen and naproxen being the most common drugs associated with peptic ulcer emergencies. It is noteworthy that the incidence of NSAID use was far higher in the study group than in a control series from the same hospital although it must be remembered that detailed drug histories were often difficult to obtain from elderly subjects. Information from most patients was obtained prospectively and we could find no difference in NSAID use between these patients and those studied by case note examination. The same four anti-inflammatory agents were most commonly prescribed in the control group and from our figures piroxicam and indomethacin were the drugs with the greatest risk of complications. The potential dangers of NSAIDs are further illustrated as in 58-2% of patients using antiinflammatory agents an acute complication was the first symptom of peptic ulceration. Moreover 'silent' perforations were seen in six patients using these drugs, of whom three died. Ulcer complications, in the absence of a history of NSAID use, were seen in a minority of patients in this study and the majority of these cases had a long history of dyspepsia. This change in incidence from the 'classical' peptic ulcer to the acute drug induced ulcer has been noted by other authors."'4'n In this study 78X2% deaths occurred in patients using NSAIDs. Complications of peptic ulceration associated with NSAID use were accompanied by a considerably greater risk of death than the similar complications in patients who were not taking these medicines. These two groups were not comparable, however, as patients using NSAIDs were older with more pre-existing cardiovascular disease and this may account for the different mortality rates, and also our control group showed that NSAID use was more common in the elderly. Nevertheless we must remember that neither age nor cardiovascular disease caused the peptic ulcers. Several patients with 'classical' ulcers were receiving effective antiulcer medication at the time of their bleed or perforation and this confirms the inherent resistance of some peptic ulcers to medical therapy. '" A similar proportion of patients using NSAIDs were simultaneously taking anti-ulcer medication because of a dyspeptic history, thus questioning the value of H,-blocking agents in the treatment and prevention of NSAID induced ulcers.'7 Where dyspepsia and peptic ulceration occurs with the use of NSAIDs then it would seem logical to try anti-ulcer drugs that enhance gastric prostaglandin activity with cytoprotection such as sucralfate and bismuth preparations."'" Our data on mortality, silent perforation, and ulcer size suggest that NSAID induced ulcers may be particularly dangerous, although this requires further investigation.
The operative mortality for bleeding ulcers requiring surgery in this study was similar to recent figures from Nottingham."' Gastric ulcers were more dangerous than duodenal and the operative mortality was increased by a factor of four in patients over 70 years confirming earlier reports."4 The operative mortality for perforations was closely related to the site of the ulcer and to age with most deaths occurring over the age of 80 years and with gastric ulcers. Patients who had an operation for bleeding or perforated peptic ulcer were more likely to die when there was a history of NSAID use and the higher operative mortality may relate to differences in age and pre-existing medical disease. It is noteworthy that four patients developed further ulcer complications related to NSAID use after vagotomy and gastrectomy suggesting that acid reducing surgical procedures do not protect the stomach and duodenum from these anti-inflammatory agents.
Life threatening complications of peptic ulceration are still common and are associated with a high mortality, especially in the elderly. Many patients died suddenly at home and these must be included in future studies. Sixty per cent of patients who developed peptic ulcer complications were using NSAIDs and in these patients an acute emergency was often the first sign of ulceration. Nearly fourfifths of all deaths occurred in patients using an antiinflammatory agent and we are at present investigating the prescribing frequency of the individual antiinflammatory agents in our area to determine their relative risks. In this study the use of NSAIDs appears to be related to the development of life threatening complications of peptic ulcer and many of the deaths and morbidity so caused may be potentially avoidable. The use of NSAIDs should be carefully controlled and these drugs should not be available 'over the counter' or used as simple analgesics. It is important for each clinician to assess the individual 'arthritic' patient to determine whether NSAID use is justified. 
